UNDBIO, a South Korean pharmaceutical company that provides diabetic care solutions, has secured a lease with West Virginia University to build an insulin manufacturing facility in Morgantown.

The company will create 200 jobs within the first three years and will invest $100M in phase one of the project.

“The mission of UNDBIO is to develop and produce state-of-the-art insulin in West Virginia,” said Caleb Jun, chairman, UNDBIO. “Our products will save human lives and improve the quality of life for those afflicted with diabetes. We are excited to see West Virginia become a mecca for manufacturing highly advanced insulin to treat diabetic patients around the world.”

In phase one, the facility will work to secure FDA approval for the product. After securing FDA approval, UNDBIO plans to expand, creating additional jobs.

“I am thrilled to make this announcement today and to welcome UNDBIO to almost heaven,” said West Virginia Gov. Jim Justice. “The addition of these good-paying jobs, with the potential for more in the future, is great news for Morgantown and for our entire state. The Morgantown area has a strong manufacturing history and I am proud that UNDBIO will join our growing list of successful, world-leading manufacturing companies who’ve chosen the Mountain State.”

Gordon Gee, president, West Virginia University, said, “We look forward to building a strong relationship with UNDBIO that can further an important part of our land-grant mission to create opportunities for our graduates, and to provide better access to health care for people across the region.”